ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
Instituto do Cancer do Estado de São Paulo
University of Chicago
Myeloid Therapeutics
Amgen
Novartis
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Xencor, Inc.
Context Therapeutics Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Klus Pharma Inc.
Theratechnologies
Exelixis
SOLTI Breast Cancer Research Group
Pfizer
Stanford University
EpicentRx, Inc.
Cybrexa Therapeutics
Carisma Therapeutics Inc
23andMe, Inc.
Salubris Biotherapeutics Inc
Hoffmann-La Roche
Eli Lilly and Company
BioEclipse Therapeutics
Multitude Therapeutics Inc.
Pfizer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
Gilead Sciences
AIDS Malignancy Consortium
Abramson Cancer Center at Penn Medicine
Canadian Cancer Trials Group
City of Hope Medical Center
University of Maryland, Baltimore
Swiss Cancer Institute
Mitra RxDx, Inc.
University of Washington
Pfizer
National Institutes of Health Clinical Center (CC)
Sanofi
National Cancer Institute (NCI)
Wake Forest University Health Sciences